Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.0% | −5.5% | −0.8% | +2.0% | +16.1% | +18.2% | +45.9% | +44.6% | +196.5% | +657.1% |
| Peer average | −1.5% | −5.1% | −2.8% | −5.1% | +15.0% | +19.1% | +61.3% | +21.3% | +153.6% | — |
| S&P 500 · VOO | −2.0% | −5.5% | −7.4% | −6.3% | +5.8% | +9.7% | +65.8% | +65.5% | +290.0% | — |
$169 of every $1,000 in XLV is Eli
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | LLYELI Lilly + | Healthcare | 16.85% | $1,685.41 | 5.8M | $8.07B |
| 2 | JNJJohnson + Johnson | Healthcare | 10.01% | $1,001.09 | 17.6M | $4.79B |
| 3 | ABBVAbbvie | Healthcare | 7.70% | $769.90 | 12.9M | $3.69B |
| 4 | MRKMerck + | Healthcare | 5.18% | $517.81 | 18.0M | $2.48B |
| 5 | UNHUnitedhealth Group | Healthcare | 4.78% | $478.44 | 6.5M | $2.29B |
| 6 | TMOThermo Fisher Scientific | Healthcare | 3.90% | $390.18 | 2.7M | $1.87B |
| 7 | AMGNAmgen | Healthcare | 3.66% | $365.57 | 3.9M | $1.75B |
| 8 | GILDGilead Sciences | Healthcare | 3.19% | $319.17 | 9.0M | $1.53B |
| 9 | ABTAbbott Laboratories | Healthcare | 2.75% | $275.40 | 12.6M | $1.32B |
| 10 | PFEPfizer | Healthcare | 2.44% | $243.63 | 41.6M | $1.17B |
| 11 | ISRGIntuitive Surgical | Healthcare | 2.27% | $226.54 | 2.6M | $1.08B |
| 12 | DHRDanaher | Healthcare | 2.18% | $217.85 | 4.6M | $1.04B |
| 13 | VRTXVertex Pharmaceuticals | Healthcare | 2.07% | $207.12 | 1.8M | $991.7M |
| 14 | MCKMckesson | Healthcare | 1.93% | $192.60 | 850K | $922.2M |
| 15 | MDTMedtronic | Healthcare | 1.88% | $187.81 | 8.9M | $899.3M |
of the $111B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | LLY | ELI Lilly + | 16.85% |
| 2 | JNJ | Johnson + Johnson | 10.01% |
| 3 | ABBV | Abbvie | 7.70% |
| 4 | MRK | Merck + | 5.18% |
| 5 | UNH | Unitedhealth Group | 4.78% |
| 6 | TMO | Thermo Fisher Scientific | 3.90% |
| 7 | AMGN | Amgen | 3.66% |
| 8 | GILD | Gilead Sciences | 3.19% |
| 9 | ABT | Abbott Laboratories | 2.75% |
| 10 | PFE | Pfizer | 2.44% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 23, 2026 | $0.64 |
| Jun 22, 2026 | Jun 24, 2026 | $0.66 |
| Mar 23, 2026 | Mar 25, 2026 | $0.59 |
| Dec 22, 2025 | Dec 24, 2025 | $0.66 |
| Sep 22, 2025 | Sep 24, 2025 | $0.62 |
| Jun 23, 2025 | Jun 25, 2025 | $0.63 |
| Mar 24, 2025 | Mar 26, 2025 | $0.56 |
| Dec 23, 2024 | Dec 26, 2024 | $0.62 |
| Sep 23, 2024 | Sep 25, 2024 | $0.58 |
| Jun 24, 2024 | Jun 26, 2024 | $0.57 |
| Mar 18, 2024 | Mar 21, 2024 | $0.52 |
| Dec 18, 2023 | Dec 21, 2023 | $0.60 |